Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAK4 | O96013 | 2/20 | 0.67 |
| ▸ | NAMPT | P43490 | 1/20 | 0.59 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.59 |
| ▸ | HRH3 | Q9Y5N1 | 8/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.32 |
| ▸ | GPR183 | P32249 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | PRKAA2 | P54646 | 2/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | STAT3 | P40763 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18530616 | 1.00 | PAK4 (0.67) | PAK4NAMPTPAK1HRH3GABRA5 | |
| SCHEMBL18542052 | 0.91 | PAK4 (0.66) | PAK4NAMPTPAK1HRH3GABRA5 | |
| SCHEMBL18542110 | 0.86 | PAK4 (0.59) | PAK4NAMPTPAK1GPR183HTR1A | |
| SCHEMBL18542053 | 0.86 | PAK4 (0.59) | PAK4NAMPTPAK1GPR183HTR1A | |
| SCHEMBL18530567 | 0.85 | PAK4 (0.59) | PAK4NAMPTPAK1GPR183HTR1A | |
| SCHEMBL18530569 | 0.85 | PAK4 (0.59) | PAK4NAMPTPAK1GPR183HTR1A | |
| SCHEMBL18317510 | 0.85 | PAK4 (0.81) | PAK4NAMPTPAK1HRH3GABRA5 | |
| SCHEMBL16379665 | 0.85 | PAK4 (0.81) | PAK4NAMPTPAK1HRH3GABRA5 | |
| SCHEMBL18530650 | 0.85 | PAK4 (0.46) | PAK4NAMPTPAK1HRH3GABRA5 | |
| SCHEMBL16347388 | 0.84 | PAK4 (0.75) | PAK4NAMPTPAK1HRH3GABRA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3337796-A1 | 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS | Karyopharm Therapeutics, Inc. (US) | 2018-06-27 | — | — | EP | disclosed |
| WO-2017031213-A1 | 3-(PYRIDIN-3-YL)-ACRYLAMIDE AND N-(PYRIDIN-3-YL)-ACRYLAMIDE DERIVATIVES AND THEIR USE AS PAK OR NAMPT MODULATORS | Karyopharm Therapeutics Inc. (US) | 2017-02-23 | — | — | WO | disclosed |